rs2307153
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001374259.2(IL12RB2):c.1394G>A(p.Gly465Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.019 in 1,610,054 control chromosomes in the GnomAD database, including 342 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001374259.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL12RB2 | NM_001374259.2 | c.1394G>A | p.Gly465Asp | missense_variant | 11/17 | ENST00000674203.2 | NP_001361188.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL12RB2 | ENST00000674203.2 | c.1394G>A | p.Gly465Asp | missense_variant | 11/17 | NM_001374259.2 | ENSP00000501329 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0147 AC: 2229AN: 152148Hom.: 21 Cov.: 32
GnomAD3 exomes AF: 0.0139 AC: 3498AN: 251434Hom.: 40 AF XY: 0.0140 AC XY: 1902AN XY: 135898
GnomAD4 exome AF: 0.0195 AC: 28393AN: 1457788Hom.: 321 Cov.: 29 AF XY: 0.0190 AC XY: 13804AN XY: 725540
GnomAD4 genome AF: 0.0146 AC: 2229AN: 152266Hom.: 21 Cov.: 32 AF XY: 0.0143 AC XY: 1067AN XY: 74446
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
IL12RB2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at